Samrat Pharmachem Ltd. | Small-cap | Basic Materials
₹307.00
-1.52%
| Samrat Pharmachem Stock Comparison:
Samrat Pharmachem vs Deepak NitriteSamrat Pharmachem vs Tata ChemicalsSamrat Pharmachem vs Styrenix PerformanceSamrat Pharmachem vs Gujarat AlkaliesSamrat Pharmachem vs Foseco India LimitedSamrat Pharmachem vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 756.5M
Gross Profit 22.6M 2.99%
Operating Income -456.0K -0.06%
Net Income -2.3M -0.30%
EPS (Diluted) ₹-0.74

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 496.9M
Shareholders Equity 718.0M
Debt to Equity 0.69

Cash Flow Metrics

Revenue & Profitability Trend

Samrat Pharmachem Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i2.9B2.8B3.1B2.2B1.8B
Cost of Goods Sold i2.7B2.7B2.8B1.9B1.7B
Gross Profit i152.7M76.8M287.7M280.8M118.7M
Gross Margin % i5.3%2.7%9.3%12.7%6.6%
Operating Expenses
Research & Development i030.0K0--
Selling, General & Administrative i14.9M18.4M18.8M12.1M11.8M
Other Operating Expenses i11.7M11.3M10.2M8.0M1.0M
Total Operating Expenses i26.6M29.7M29.0M20.1M12.8M
Operating Income i97.5M18.7M233.9M237.8M87.4M
Operating Margin % i3.4%0.7%7.5%10.7%4.9%
Non-Operating Items
Interest Income i3.4M2.8M1.8M1.4M864.0K
Interest Expense i4.9M5.5M9.3M3.6M9.4M
Other Non-Operating Income-----
Pre-tax Income i98.9M25.2M225.3M236.0M73.4M
Income Tax i27.7M3.6M59.0M64.2M20.1M
Effective Tax Rate % i28.1%14.2%26.2%27.2%27.4%
Net Income i71.1M21.6M166.3M171.8M53.3M
Net Margin % i2.5%0.8%5.4%7.7%3.0%
Key Metrics
EBITDA i107.2M27.1M240.8M245.5M90.2M
EPS (Basic) i₹23.02₹7.00₹53.83₹55.62₹17.26
EPS (Diluted) i₹23.02₹7.00₹53.83₹55.62₹17.26
Basic Shares Outstanding i30897003089700308970030897003089700
Diluted Shares Outstanding i30897003089700308970030897003089700

Income Statement Trend

Samrat Pharmachem Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i483.0K96.7M118.6M147.0M25.1M
Short-term Investments i3.6M109.0K139.0K100.0K10.0K
Accounts Receivable i565.4M692.8M516.7M435.7M330.1M
Inventory i380.1M206.8M325.3M124.2M114.0M
Other Current Assets82.8M49.0K50.0K200.0K367.0K
Total Current Assets i1.0B1.0B990.5M712.6M473.2M
Non-Current Assets
Property, Plant & Equipment i00107.0M99.8M93.9M
Goodwill i146.0K66.0K75.0K85.0K95.0K
Intangible Assets i146.0K66.0K75.0K85.0K95.0K
Long-term Investments-----
Other Non-Current Assets-6.1M497.0K1.0K-3.0K
Total Non-Current Assets i181.3M191.7M175.4M133.5M100.7M
Total Assets i1.2B1.2B1.2B846.1M574.0M
Liabilities
Current Liabilities
Accounts Payable i385.6M476.7M318.8M233.9M176.6M
Short-term Debt i99.1M84.5M186.6M75.2M87.9M
Current Portion of Long-term Debt-----
Other Current Liabilities22.0K-6.0K493.0K8.9M1.7M
Total Current Liabilities i495.8M564.0M531.9M373.3M273.3M
Non-Current Liabilities
Long-term Debt i00000
Deferred Tax Liabilities i1.1M3.4M2.5M4.6M4.3M
Other Non-Current Liabilities-6.0K---1.0K
Total Non-Current Liabilities i1.1M3.4M2.5M4.6M4.3M
Total Liabilities i496.9M567.4M534.5M377.9M277.6M
Equity
Common Stock i30.9M30.9M30.9M30.9M30.9M
Retained Earnings i687.1M619.1M600.5M437.3M265.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i718.0M650.0M631.4M468.2M296.4M
Key Metrics
Total Debt i99.1M84.5M186.6M75.2M87.9M
Working Capital i537.8M461.7M458.6M339.3M200.0M

Balance Sheet Composition

Samrat Pharmachem Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i98.9M25.2M225.3M236.0M73.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-100.9M-65.1M-326.1M-115.1M34.4M
Operating Cash Flow i1.3M-35.9M-90.3M126.4M119.7M
Investing Activities
Capital Expenditures i-5.1M-6.5M-13.6M-12.0M-16.5M
Acquisitions i-----
Investment Purchases i-417.5M-305.3M-85.2M-85.2M-
Investment Sales i418.8M304.7M66.8M85.2M-
Investing Cash Flow i-3.7M-7.1M-32.0M-12.0M-16.5M
Financing Activities
Share Repurchases i-----
Dividends Paid i-3.1M-3.1M-3.1M--
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i11.5M-105.1M108.3M-12.7M-3.0M
Free Cash Flow i-106.0M87.5M-109.0M162.0M20.7M
Net Change in Cash i9.0M-148.1M-14.0M101.7M100.2M

Cash Flow Trend

Samrat Pharmachem Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 20.00
Price to Book 1.34
Price to Sales 0.34
PEG Ratio -0.18

Profitability Ratios

Profit Margin 1.72%
Operating Margin -0.06%
Return on Equity 9.91%
Return on Assets 5.85%

Financial Health

Current Ratio 2.08
Debt to Equity 13.81
Beta -0.40

Per Share Data

EPS (TTM) ₹15.59
Book Value per Share ₹232.02
Revenue per Share ₹908.08

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
samratph1.0B20.001.349.91%1.72%13.81
Deepak Nitrite 253.6B41.674.6911.85%7.58%23.36
Tata Chemicals 236.6B75.131.112.17%2.27%31.43
Styrenix Performance 43.5B19.233.7220.14%7.00%34.02
Gujarat Alkalies 41.8B70.120.68-1.15%-0.82%9.30
Foseco India Limited 36.0B43.679.6724.30%14.05%0.42

Financial data is updated regularly. All figures are in the company's reporting currency.